EUVIMEDEUVIMED entdecken
Crossref

Psychobiotics and the Microbiota–Gut–Brain Axis: Mechanistic Insights, Multi‐Omics Advances, and Therapeutic Potential in Mental and Systemic Disorders

Mudassar Mohiuddin

Journal of Food Science · 2026-11 · 91 (11)

DOI: 10.1111/1750-3841.71650 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Food Science, online erschienen am 19.11.2026. Verfasst von Mudassar Mohiuddin. Die Arbeit nennt 277 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Common mental illnesses, such as anxiety, depression, and neurodegenerative diseases, are increasing worldwide, and there is increasing evidence that their pathogenesis is associated with gut microbiota dysbiosis and disruption of the microbiota–gut–brain axis (MGBA). Nevertheless, there is a lack of mechanistic understanding and clinical translation of psychobiotics. This review consolidates the results of preclinical, clinical, and multi‐omics research to assess the role of psychobiotics, such as prebiotics, probiotics, synbiotics, and postbiotics, in regulating MGBA pathways, including endocrine, immune, neural, and metabolic pathways, along with developments in metabolite detection and microbial profiling. Psychobiotics normalize the intestinal microbial composition, increase the intestinal barrier integrity, and balance neuroinflammation. They modulate the levels of major neurotransmitters (dopamine, serotonin, γ‐aminobutyric acid) and suppress hyperactivity of the hypothalamic–pituitary–adrenal (HPA) axis. There is growing evidence showing their therapeutic efficacy in gastrointestinal, metabolic, autoimmune, and neuropsychiatric diseases, including anxiety, depression, and Alzheimer's and Parkinson's diseases. Synergistic effects with neuro‐nutrition and physical activity further enhance cognitive function and neuroplasticity. Psychobiotics provide a mechanism‐based approach to address interconnected pathways of the MGBA, which is an exciting addition to traditional treatments with an excellent safety profile. Precision psychobiotic intervention and translation of multi‐omics approaches into clinical practice require standardized and large‐scale clinical trials as well as integration of these methods.

Zitieren

APA

Mohiuddin, M. (2026). Psychobiotics and the Microbiota–Gut–Brain Axis: Mechanistic Insights, Multi‐Omics Advances, and Therapeutic Potential in Mental and Systemic Disorders. Journal of Food Science, 91(11). https://doi.org/10.1111/1750-3841.71650

Vancouver

Mohiuddin M. Psychobiotics and the Microbiota–Gut–Brain Axis: Mechanistic Insights, Multi‐Omics Advances, and Therapeutic Potential in Mental and Systemic Disorders. Journal of Food Science. 2026;91(11). doi:10.1111/1750-3841.71650

BibTeX
@article{Mohiuddin2026,
  author = {Mohiuddin, Mudassar},
  title = {Psychobiotics and the Microbiota–Gut–Brain Axis: Mechanistic Insights, Multi‐Omics Advances, and Therapeutic Potential in Mental and Systemic Disorders},
  journal = {Journal of Food Science},
  year = {2026},
  volume = {91},
  number = {11},
  doi = {10.1111/1750-3841.71650}
}
Kostenlos starten →